Novo Nordisk A/S
The Regulatory Affairs Director at Novo Nordisk will lead global regulatory strategies for complex lifecycle management projects, acting as a strategic partner across the value chain and engaging with major health authorities. The role involves shaping regulatory approaches, guiding cross‑functional teams, and ensuring alignment between scientific innovation, business goals, and regulatory requirements.
Headquarters
Alle, Central Jutland, Denmark
Company Size
10001+ employees
Founded
1923
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, with the stated purpose of driving change to defeat diabetes and other serious chronic diseases. It researches, develops, manufactures and markets pharmaceutical products and medical devices across diabetes care, obesity, haemophilia, growth disorders and other endocrine conditions, and is widely known for its insulin and GLP‑1 therapies. Combining extensive R&D, large‑scale manufacturing and global commercial reach, Novo Nordisk emphasizes patient‑centred care, access programs and sustainability in its work to improve outcomes for people with chronic disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk A/S.
Novo Nordisk A/S didn’t post a salary, so this is our estimate from similar listings.
42% below the average for this role
Regulatory Affairs Strategy Director
AstraZeneca
Regulatory Professional - Regulatory Affairs
State of Indiana
Regulatory Affairs and Pharmacovigilance Associate Director
State of Indiana
Regulatory Affairs Director (RAD)
AstraZeneca
Director, Regulatory Affairs
Allucent
Executive Director/VP Regulatory Affairs
Erasca